Filing Flows › Companies › AstraZeneca › Timeline
AstraZeneca stock timeline
A year of the price with every insider trade, planned sale, earnings report and material 8-K marked
252 sessions+12.4% to $186.43
AstraZeneca (AZN) stock rose 12% over the last 252 sessions, to $186.43. On the way it reported 0 quarters, its insiders filed 1 open-market trade, and the company filed 0 material 8-Ks. Each is marked on the price and listed with what the stock did next.
Each mark, and what followed
| Date | Kind | What | Next session | 5 sessions | 21 sessions |
|---|---|---|---|---|---|
| May 20, 2026 | Insider sale | Sharma Mani sold $2.2M | +1.5% (+0.5% vs SPY) | +0.5% (−1.7% vs SPY) | −5.4% (−7.4% vs SPY) |
Insiders’ record here
In the year on the chart, AstraZeneca's insiders reported 0 open-market buys ($0) and 1 sale ($2.2M). Of the 1 old enough to score, 1 were followed by the stock doing what the trade implied over the next 63 sessions (beating SPY after a buy, lagging it after a sale); the median excess return after a buy was — and after a sale −15.1%.
Across the whole universe (19,780 scored trades), insider buys beat the market 46% of the time and sales were followed by a lagging stock 61% of the time; buys of $1M or more 39%. Every pattern →
AstraZeneca: every quarter → Live insider trades →
Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.